Targeting Metabolic Mechanism Restores Chemotherapy Sensitivity in Ovarian Cancer Genetic Engineering and Biotechnology News αKG-mediated carnitine synthesis drives DNA repair via histone acetylation Nature Temple University researchers uncover metabolic weakness in ovarian cancer Temple Now Far right: Wistar's Dr. Katherine Aird and lab (IMAGE) EurekAlert! Wistar Institute and Temple Scientists Identify Metabolic Target to Overcome Chemotherapy Resistance in Ovarian Cancer | Newswise Newswise